3860 results for «2324»

Filter By

3860 results

Beyond the evolution! Latest image guided therapy for structural heart disease intervention 2.0 era

16 Feb 2020 – From PCR Tokyo Valves 2020

Consult this session in japanese to learn more about EchoNavigator, an innovative tool for guidance of interventional procedures in structural heart disease, and discover how it may help you achieve a better patient outcome.

Beyond the evolution!  Latest image guided therapy for structural heart disease intervention 2.0 era

How to optimise PCI in a patient with multivessel disease? LIVE Case

19 Dec 2019 – From GulfPCR-GIM 2019

Watch this case of an 81-year-old female with no prior history of CAD who presented with unstable angina. The patient had recent acute coronary syndrome and baseline angiography shows multivessel disease.

The objectives of this case are:

  1. Assess your patient as a whole package!
  2. Lesion preparation is key for...
How to optimise PCI in a patient with multivessel disease? LIVE Case

Imaging Day - Case-based imaging for the mitral valve

14 Feb 2020 – From PCR Tokyo Valves 2020

Which imaging is most relevant to clinical decision-making and procedural planning? Find out more on the pathophysiology of mitral regurgitation.

Imaging Day - Case-based imaging for the mitral valve

Learnings from a decade-long experience of transcatheter mitral valve repair procedures with MitraClipTM

15 Feb 2020 – From PCR Tokyo Valves 2020

Consult this session to learn more about the patient selection and procedure for MitraClip, and discover how to decide endpoint and assess procedural outcome after this intervention, and how to avoid potential complications, such as chordal entanglement. 

Learnings from a decade-long experience of TMVR procedures with MitraClipTM

Sizes, wires, and other innovations in TAVI technique and technology

15 Feb 2020 – From PCR Tokyo Valves 2020

Consult this session on innovations in TAVI technique and technology to learn more about new self-expanding TAVR valve sizes and TAVR wires, emerging developments in self-expandable TAVR implant best practices, and discover how to utilize these new technologies and techniques to achieve the best possible outcomes for AS patients.

Sizes, wires, and other innovations in TAVI technique and technology

MitraClip case in point in Japanese

16 Feb 2020 – From PCR Tokyo Valves 2020

Find out more on the MitraClip NT System Japan post market surveillance, the MitraClip best practice and challenging functional MR cases...

Remaining challenges in TAVI: how to achieve the better lifetime outcomes for AS patients

16 Feb 2020 – From PCR Tokyo Valves 2020

Consult this session to gain insight into the remaining challenges in TAVI, such as providing AS patients with the best possible outcomes over their entire lifetime, improving pacemaker implant rates with self-expandable valves, and more!

Remaining challenges in TAVI: how to achieve the better lifetime outcomes for AS patients

Challenging cases on mitral interventions, TAVI and LAA closure

15 Feb 2020 – From PCR Tokyo Valves 2020

Consult this session to discover various challenging cases, such as: systolic anterior motion with mitral regurgitation triggered by TAVI, transcatheter mitral valve repair using MitraClip through atrial septal defect, ACS complicating transcaval TAVI, and more!

Morning cases

Abstracts in Japanese

15 Feb 2020 – From PCR Tokyo Valves 2020

Consult this session to discover a selection of abstracts submitted during PCR Tokyo Valves 2020, such as: impact of beta blockers on patients undergoing TAVR, predictive factors of no symptomatic improvement after TAVI, and more!

Abstracts in Japanese

Challenging cases

15 Feb 2020 – From PCR Tokyo Valves 2020

Consult this session to discover challenging TAVI cases and high-risk procedures, regarding pulmonic valve stenosis and PPM, calcific aortic stenosis, degenerative aortic stenosis, and more. Watch it now to discover the chosen treatment!

Challenging cases

TAVI and others

15 Feb 2020 – From PCR Tokyo Valves 2020

Consult this session to learn more about a study comparing the treatment's results of patients with bicuspid (BAV) and tricuspid aortic valve (TAV), in whom TAVI was performed, in terms of device success, early safety and clinical efficacy.

TAVI and others

Complication cases

15 Feb 2020 – From PCR Tokyo Valves 2020

Consult this session to learn through a selection of complications cases how to manage transcatheter aortic valve migration, aorto-right ventricular fistula after TAVI, and sudden haemodynamic collapse during TAVI.

Complication cases

Session for the Co-medicals in Japanese

15 Feb 2020 – From PCR Tokyo Valves 2020

Consult this session dedicated to the co-medicals, to discover the nurse's perspective on percutaneous LAA closure, a study on the reduction of scattered radiation exposure in TAVI, and more!

Session for the Co-medicals in Japanese

Improving patient access and clinical outcomes in the treatment of aortic stenosis - The Edwards Benchmark Program

18 Nov 2019 – From PCR London Valves 2019

Consult this session to learn more about the current and future constraints on aortic stenosis treatment in Europe, and gain insight into the Edwards Benchmark Program, aiming to optimize patient outcomes, care pathway and efficiency.

Improving patient access and clinical outcomes in the treatment of aortic stenosis

Heart Team 2.0 in action: how to manage complex TAVI procedures

18 Nov 2019 – From PCR London Valves 2019

Consult this session to learn how to plan a successful TAVI procedure for your patients with challenging anatomy and high-risk clinical characteristics, such as: with a bicuspid aortic valve and associated aortopathy, with severe LVOT calcification, with a high risk of left main coronary occlusion, and more!

Heart Team 2.0 in action: how to manage complex TAVI procedures

Will PARTNER-3 and Evolut low-risk trials change my practice?

18 Nov 2019 – From PCR London Valves 2019

Consult this session to learn all about PARTNER-3 and Evolut trials, and gain an in-depth understanding of these trials comparing TAVI and SAVR in patients at low surgical risk, while appreciating their limitations and key remaining questions.

Will PARTNER-3 and Evolut low-risk trials change my practice?

Innovations in transcatheter tricuspid valve intervention

18 Nov 2019 – From PCR London Valves 2019

Consult this session to learn all about the innovations in transcatheter tricuspid valve intervention: discover the new transcatheter treatment strategies, improve your understanding of the clinical indications for intervention, and appreciate the challenges and limitations of tricuspid valve imaging before and during the intervention.

Innovations in transcatheter tricuspid valve intervention

Case-based learning for the Heart Team: patient selection for tricuspid valve interventions

18 Nov 2019 – From PCR London Valves 2019

Consult this session on patient selection for tricuspid valve interventions to gain insights into how clinical and anatomical characteristics influence patient and device selection, and to become more familiar with the key steps in transcatheter tricuspid valve procedures.

Case-based learning for the Heart Team: patient selection for tricuspid valve interventions

Controversy - Challenges for the Heart Team II - Mitral regurgitation and heart failure - Where two worlds meet

19 Nov 2019 – From PCR London Valves 2019

Consult this session on mitral regurgitation and heart failure to hear the latest thinking concerning the optimal management of patients suffering from these diseases, and discover the implications of recent trials for your clinical practice, such as COAPT, MITRA-FR, and more!

Controversy - Challenges

Heart Team 2.0 in action: TAVI or SAVR in younger lower-risk patients?

18 Nov 2019 – From PCR London Valves 2019

Consult this session on TAVI vs SAVR in younger lower-risk patients to learn all about the outcomes of various recent trials and how to translate them into your clinical practice, thanks to a selection of challenging cases involving bicuspid aortic valve disease, small aortic annulus, and complex...

Heart Team 2.0 in action: TAVI or SAVR in younger lower-risk patients?
Didn’t find what you were looking for?